LFCR Q1 2023 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$24M-43.0% YoY

Gross Profit

$6M25.2% margin

Operating Income

-$3M-13.8% margin

Net Income

-$11M-46.2% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-50.2%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$286M

Total Liabilities

$189M

Stockholders' Equity

$97M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$42M	-43.0%
Gross Profit	$6M	$10M	-42.7%
Operating Income	-$3M	-$3M	-19.4%
Net Income	-$11M	-$9M	-15.7%